Evidence map›Paper›PMID 40165154›Full record

ArticleBMC public health2025

Comparison of the cumulative exposure to four measures of blood pressure for predicting cardiovascular disease risk in the Chinese Uyghurs.

Jing Cheng, Bo Yang, Ru-Lin Ma, Jia He, Dong-Sheng Rui, Yu Li, Xiang-Hui Zhang, Le-Yao Jian, Jia-Hang Li, Shu-Xia Guo and 1 more

Abstract readComparative Study
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing Cheng *Department of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Bo Yang *Department of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Ru-Lin MaDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Jia HeDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Dong-Sheng RuiDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Yu LiDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Xiang-Hui ZhangDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Le-Yao JianDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Jia-Hang LiDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Shu-Xia GuoDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China.
Heng GuoDepartment of Public Health, Shihezi University School of Medicine, North 2th Road, Shihezi, Xinjiang, 832003, China. guoheng@shzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to explore and compare the role of cumulative exposure to four blood pressure (BP) markers [systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure (PP)] in predicting cardiovascular disease (CVD) risk in the Uyghur population.

methodsWe recruited 3,553 Uyghurs from Tumxuk City, and conducted blood pressure measurements on them at least three times, with a minimum interval of two years between consecutive measurements. Cumulative BP was defined as the sum of the product of the average BP between consecutive examinations and the time interval between visits. Cox proportional hazard models and restricted cubic spline (RCS) analysis were used to estimate the association between cumBP and CVD risk. The incremental predictive value of cumBP was further assessed using the net reclassification index (NRI) and integrated discrimination improvement (IDI).

resultsOver a median follow-up of 6.29 years, 383 (10.78%) incidents of CVD occurred. All four cumBP markers were associated with CVD risk, with cumulative SBP (cumSBP) and cumulative PP (cumPP) showing the strongest associations. For each 1-SD increase in cumSBP and cumPP, the CVD risk increased by 31% [HR (95% CI): 1.310 (1.153, 1.489)] and 28% [HR (95% CI): 1.284 (1.132, 1.457)], respectively. Additionally, 1-SD values corresponded to 107.90 mmHg·years for cumSBP and 65.33 mmHg·years for cumPP. RCS analysis showed a linear relationship between cumBP and CVD risk. CumSBP provided the best incremental predictive value for CVD after adding cumSBP to the conventional model, improving the NRI by 0.126 (P = 0.019) and the IDI by 0.009 (P = 0.001). Although cumulative MAP and cumulative PP also improved the predictive capabilities to varying degrees, the effect sizes were smaller than those of cumSBP.

conclusionAll four cumBP markers were significantly associated with CVD risk in this population. Compared with the other three cumBP measures, cumSBP had the strongest association with CVD events and provided a superior incremental predictive value for CVD events.

Indexed as

Blood PressureBlood Pressure DeterminationCardiovascular DiseasesCentral Asian PeopleAdultAgedChinaFemaleHumansMaleMiddle AgedPredictive Value of TestsProportional Hazards ModelsRisk AssessmentCardiovascular diseaseCumulative exposureDiastolic blood pressureMean arterial pressurePredictionPulse pressureSystolic blood pressure

Identifiers

PMID40165154
PMCPMC11956206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.